Pharmafile Logo

The Trust Test

- PMLiVE

MSF: TPP agreement could swell healthcare costs

But proponents say it will boost economic development

- PMLiVE

Spark set to file eye disease gene therapy next year

SPK-RPE65 shows significant benefit in functional vision for patients with retinal dystropies

Social network for doctors SERMO launches Spanish version

Marksthe first non-English capability for the US company

- PMLiVE

Clock ticking on biosimilar Enbrel in US

10-month review for drug

- PMLiVE

Merck gets lung cancer OK for Keytruda in US

Highlights increased understanding of molecular processes in cancer

MSD launches preventative healthcare accelerator

Joins forces with Wayra Open Future for VelocityHealth fund

- PMLiVE

Novartis signs $500m immuno-oncology deal

Gains access to Xoma's TGFb antibody programme

Teva Pharma logo

TEVA buys Mexico’s RIMSA for $2.3bn

Follows acquisition ofAllergan’s generic drugs business

- PMLiVE

IBM teams up with Teva for global eHealth collaboration

Willalso partner with ICON on cancer trials project

- PMLiVE

Merck takes novel immuno-oncology drug into clinical trials

Potential to offer alternative to anti-PD-1/anti-PDL1 immunotherapies 

- PMLiVE

Genzyme opts into gene silencing therapy for haemophilia

Interim results show positive benefits for ALN-AT3

ABPI’s Stephen Whitehead steps down

Leaves the UK pharma trade body after four years as its CEO

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links